Long -Term Kidney Outcomes among Users of Proton Pump Inhibitors

Nehal Magdy Messiha Abdelmalak;

Abstract


SUMMARY
T
o summarize, PPIs represent an essential part of the modern gastroenterologist’s armament for combating everyday clinical problems. In general, they are highly efficacious in the treatment of acid-related disorders.
While PPIs are generally considered safe and well tolerated, more serious adverse events have been reported. The risk of pneumonia was increased 27–39% in short-term use of PPIs in three meta-analyses. The use of PPIs is associated with Clostridium difficile infection and appears to be dose related. Fractures and the impaired magnesium absorption associated with the use of PPIs have led the FDA to issue a warning regarding their use. Thrombocytopenia, iron deficiency, vitamin B12 deficiency, rhabdomyolysis and acute interstitial nephritis have also been reported with the use of PPIs.
Some recent studies has suggested that Proton pump inhibitor use is linked with a higher risk of chronic kidney disease (CKD) being held on a large number of patients with different co-morbidities and chronic diseases for a long period of time.


Other data

Title Long -Term Kidney Outcomes among Users of Proton Pump Inhibitors
Other Titles مثبطات مضخة البروتون ونتائج استخدامها طويل المدى على الكلى
Authors Nehal Magdy Messiha Abdelmalak
Issue Date 2017

Attached Files

File SizeFormat
J3332.pdf315.85 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.